2022
DOI: 10.1093/sleep/zsac003
|View full text |Cite
|
Sign up to set email alerts
|

Associations of sleep and circadian phenotypes with COVID-19 susceptibility and hospitalization: an observational cohort study based on the UK Biobank and a two-sample Mendelian randomization study

Abstract: Study Objectives Sleep and circadian phenotypes are associated with several diseases. The present study aimed to investigate whether sleep and circadian phenotypes were causally linked with coronavirus disease 2019 (COVID-19)-related outcomes. Methods Habitual sleep duration, insomnia, excessive daytime sleepiness, daytime napping, and chronotype were selected as exposures. Key outcomes included positivity and hospitalization… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 37 publications
0
7
0
Order By: Relevance
“…13,14 Unhealthy sleep dimensions individually and in combination (eg, late chronotype, short or long duration of sleep, snoring and sleep apnea, and daytime sleepiness) are prospectively associated with COVID-19 susceptibility, severity, and mortality. [15][16][17][18] Mendelian randomization analyses have further identified insomnia, extreme sleep duration, and excessive daytime sleepiness as causal risk factors for the severity of COVID-19 and other respiratory infections. 16,17,19 These unhealthy sleep dimensions have been linked to chronic low-grade inflammation and immune abberations, 12,20,21 which have been implicated in the pathogenesis of PCC and other postinfection syndromes, such as postviral fatigue syndrome.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…13,14 Unhealthy sleep dimensions individually and in combination (eg, late chronotype, short or long duration of sleep, snoring and sleep apnea, and daytime sleepiness) are prospectively associated with COVID-19 susceptibility, severity, and mortality. [15][16][17][18] Mendelian randomization analyses have further identified insomnia, extreme sleep duration, and excessive daytime sleepiness as causal risk factors for the severity of COVID-19 and other respiratory infections. 16,17,19 These unhealthy sleep dimensions have been linked to chronic low-grade inflammation and immune abberations, 12,20,21 which have been implicated in the pathogenesis of PCC and other postinfection syndromes, such as postviral fatigue syndrome.…”
Section: Introductionmentioning
confidence: 99%
“…[15][16][17][18] Mendelian randomization analyses have further identified insomnia, extreme sleep duration, and excessive daytime sleepiness as causal risk factors for the severity of COVID-19 and other respiratory infections. 16,17,19 These unhealthy sleep dimensions have been linked to chronic low-grade inflammation and immune abberations, 12,20,21 which have been implicated in the pathogenesis of PCC and other postinfection syndromes, such as postviral fatigue syndrome. [22][23][24] Despite experimental evidence supporting the role of sleep deprivation and disturbances in infectious disease prognosis via immune dysfunction, 20,25 the association between sleep health prior to SARS-CoV-2 infection and risk of PCC has not been investigated.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Daytime sleepiness is also found to be a risk for COVID-19 hospitalization. 29 The mechanism underlying the link between short sleep and prolonged virus shedding in SARS-CoV-2 Omicroninfected patients is still unknown. One plausible mechanism could be the adverse effect of insufficient sleep on immune system.…”
Section: Discussionmentioning
confidence: 99%
“…In SLEEP , Zheran Liu et al [ 5 ] address this issue by analyzing epidemiological and genetic data from the community-based UK Biobank and the COVID-19 Host Genetic Initiative using Mendelian randomization (MR) analyses. This study is notable given the large number of participants enrolled (>500 000) with both phenotypic and genotypic data acquired at baseline between 2006 and 2010.…”
mentioning
confidence: 99%